AcouSort AB (publ) (STO:ACOU)
Sweden · Delayed Price · Currency is SEK 2.570
+0.430 (20.09%)
At close: Feb 10, 2026
AcouSort AB Market Cap
AcouSort AB has a market cap or net worth of 54.39 million as of February 10, 2026. Its market cap has decreased by -62.84% in one year.
Market Cap
54.39M
Enterprise Value
42.56M
Revenue
10.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.57
Market Cap Chart
Since January 9, 2017, AcouSort AB's market cap has decreased from 65.36M to 54.39M, a decrease of -16.78%. That is a compound annual growth rate of -2.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 54.39M | -9.19% |
| Dec 30, 2025 | 59.89M | -63.54% |
| Dec 30, 2024 | 164.28M | -29.12% |
| Dec 29, 2023 | 231.76M | 18.13% |
| Dec 30, 2022 | 196.19M | -41.95% |
| Dec 30, 2021 | 337.98M | 24.44% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 9, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alligator Bioscience AB | 96.21M |
| Spago Nanomedical AB | 83.03M |
| Scandinavian ChemoTech AB | 82.87M |
| Alzinova AB | 73.97M |
| OncoZenge AB | 70.57M |
| ExpreS2ion Biotech Holding AB | 54.65M |
| Pila Pharma AB | 50.75M |
| 2cureX AB | 48.95M |